These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25573162)

  • 1. Heteromers of amyloid precursor protein in cerebrospinal fluid.
    Cuchillo-Ibañez I; Lopez-Font I; Boix-Amorós A; Brinkmalm G; Blennow K; Molinuevo JL; Sáez-Valero J
    Mol Neurodegener; 2015 Jan; 10():2. PubMed ID: 25573162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.
    Brinkmalm G; Brinkmalm A; Bourgeois P; Persson R; Hansson O; Portelius E; Mercken M; Andreasson U; Parent S; Lipari F; Ohrfelt A; Bjerke M; Minthon L; Zetterberg H; Blennow K; Nutu M
    Brain Res; 2013 Jun; 1513():117-26. PubMed ID: 23541617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition.
    Dobrowolska JA; Michener MS; Wu G; Patterson BW; Chott R; Ovod V; Pyatkivskyy Y; Wildsmith KR; Kasten T; Mathers P; Dancho M; Lennox C; Smith BE; Gilberto D; McLoughlin D; Holder DJ; Stamford AW; Yarasheski KE; Kennedy ME; Savage MJ; Bateman RJ
    J Neurosci; 2014 Jun; 34(24):8336-46. PubMed ID: 24920637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
    Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
    Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus.
    Miyajima M; Nakajima M; Ogino I; Miyata H; Motoi Y; Arai H
    Eur J Neurol; 2013 Feb; 20(2):236-42. PubMed ID: 22672777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
    Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
    J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment.
    Araki W; Kanemaru K; Hattori K; Tsukamoto T; Saito Y; Yoshida S; Takano H; Sakata M; Yokoi Y; Omachi Y; Nagaoka U; Nagao M; Komori T; Tachimori H; Murayama S; Mizusawa H
    Aging Clin Exp Res; 2022 Feb; 34(2):341-347. PubMed ID: 34283410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid.
    Alexopoulos P; Tsolakidou A; Roselli F; Arnold A; Grimmer T; Westerteicher C; Leante MR; Förstl H; Livrea P; Kurz A; Perneczky R
    Alzheimers Dement; 2012 Jul; 8(4):304-11. PubMed ID: 22055653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease.
    Rosén C; Andreasson U; Mattsson N; Marcusson J; Minthon L; Andreasen N; Blennow K; Zetterberg H
    Neuromolecular Med; 2012 Mar; 14(1):65-73. PubMed ID: 22350541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease.
    Wu G; Sankaranarayanan S; Wong J; Tugusheva K; Michener MS; Shi X; Cook JJ; Simon AJ; Savage MJ
    J Neurosci Res; 2012 Dec; 90(12):2247-58. PubMed ID: 22987781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease.
    Perneczky R; Tsolakidou A; Arnold A; Diehl-Schmid J; Grimmer T; Förstl H; Kurz A; Alexopoulos P
    Neurology; 2011 Jul; 77(1):35-8. PubMed ID: 21700579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.
    Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H
    BMC Neurol; 2009 Dec; 9():63. PubMed ID: 20028512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer's disease.
    Rose C; Peoc'h K; Chasseigneaux S; Paquet C; Dumurgier J; Bourasset F; Calon F; Laplanche JL; Hugon J; Allinquant B
    BMC Neurosci; 2012 Jul; 13():84. PubMed ID: 22824057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.
    Alcolea D; Martínez-Lage P; Sánchez-Juan P; Olazarán J; Antúnez C; Izagirre A; Ecay-Torres M; Estanga A; Clerigué M; Guisasola MC; Sánchez Ruiz D; Marín Muñoz J; Calero M; Blesa R; Clarimón J; Carmona-Iragui M; Morenas-Rodríguez E; Rodríguez-Rodríguez E; Vázquez Higuera JL; Fortea J; Lleó A
    Neurology; 2015 Aug; 85(7):626-33. PubMed ID: 26180139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF sAPPα and sAPPβ levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis.
    Tang W; Wang Y; Cheng J; Yao J; Yao YY; Zhou Q; Guan SH
    Neuromolecular Med; 2020 Mar; 22(1):45-55. PubMed ID: 31414383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
    Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V
    PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of plasma soluble amyloid precursor protein beta in Alzheimer's disease.
    Yun SM; Cho SJ; Jo C; Park MH; Han C; Koh YH
    Arch Gerontol Geriatr; 2020; 87():103995. PubMed ID: 31874328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sAPPβ and sAPPα increase structural complexity and E/I input ratio in primary hippocampal neurons and alter Ca
    Hesse R; von Einem B; Wagner F; Bott P; Schwanzar D; Jackson RJ; Föhr KJ; Lausser L; Kroker KS; Proepper C; Walther P; Kestler HA; Spires-Jones TL; Boeckers T; Rosenbrock H; von Arnim CAF
    Exp Neurol; 2018 Jun; 304():1-13. PubMed ID: 29466703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
    Dobrowolska JA; Kasten T; Huang Y; Benzinger TL; Sigurdson W; Ovod V; Morris JC; Bateman RJ
    PLoS One; 2014; 9(3):e89998. PubMed ID: 24646516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases.
    van Waalwijk van Doorn LJ; Koel-Simmelink MJ; Haußmann U; Klafki H; Struyfs H; Linning P; Knölker HJ; Twaalfhoven H; Kuiperij HB; Engelborghs S; Scheltens P; Verbeek MM; Vanmechelen E; Wiltfang J; Teunissen CE
    J Neurochem; 2016 Apr; 137(1):112-21. PubMed ID: 26748905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.